chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stiffness of the neck; Weakness in the body; Headaches; A little achiness, gotten worse, feel achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (A little achiness, gotten worse, feel achy), MUSCULOSKELETAL STIFFNESS (Stiffness of the neck), ASTHENIA (Weakness in the body) and HEADACHE (Headaches) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN (A little achiness, gotten worse, feel achy). On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness of the neck), ASTHENIA (Weakness in the body) and HEADACHE (Headaches). At the time of the report, PAIN (A little achiness, gotten worse, feel achy), MUSCULOSKELETAL STIFFNESS (Stiffness of the neck), ASTHENIA (Weakness in the body) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
gave dose that had expired; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B) (batch number unknown, expiry date 14th September 2021) for prophylaxis.   On 28th September 2021, the patient received Engerix B. On 28th September 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were reported as follows: The age at vaccination was not reported. A pharmacist gave a dose of Engerix-B that had expired which led to expired vaccine used. The reporter consented to follow up.
Left deltoid with swelling, hypoedema, warm to touch area with MMR/DTAP vaccine given on 10/02/2003.
Patient arrived to the ED on 12/27/2021 with shortness of breath and bilateral leg swelling  +COVID  Generalized malaise and weakness, shortness of breath , mild cough . O2sat 89% on room air
Three days after experienced fever of 103, chills, body aches, chest pain and shortness of breath.
Patient was given Fluzone HD injection instead of Fluvirin trivalent.  Fluzone HD is not indicated for patient age.  Patient did not report any adverse effects.
Information has been received from a certified medical assistant reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 06-NOV-2017, the patient received an improperly stored dose of M-M-R II for prophylaxis, lot # N013867, expiration date 04-MAY-2019 (strength, dose, anatomical location and route of administration were not reported). The vaccine was reconstituted with properly stored sterile diluent lot # N026990, expiration date 26-SEP-2018. No adverse effect reported. It was reported that on an unspecified date, the vaccine was exposed to a temperature between 9 degrees Celsius and 25 degrees Celsius for 1 hour and 5 minutes. The certified medical assistant reported that there was no previous temperature excursion. The call was placed because of a Digital Data logger report.
8:30 am on 2/23/2011. C/o feeling pain. Mild fever (101) very tired. Did not go to school stayed home & slept on couch all day. Parents gave TYLENOL to help with symptoms.
Patient is under 18 and received a dose of moderna COVID-19 vaccine, which is approved for user in 18 and older
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a first dose of GARDASIL.  Subsequently, right after the vaccination the patient experienced pain in vaccinated arm, pain in chest, pain in neck, and shortness of breath.  Unspecified medical attention was sought.  The symptoms lasted a few days and then the patient recovered.  On an unspecified date was vaccinated with a second dose of GARDASIL.  Subsequently, right after the vaccination the patient experienced pain in vaccinated arm, pain in chest, pain in neck, and shortness of breath.  Unspecified medical attention was sought.  The symptoms lasted a few days and then the patient recovered.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 9/17/2007. Initial and follow-up information has been received from a physician conderning a 16 year old female student with allergic rhinitis, who, on 21-FEB-2007, was vaccinated intramuscularly in the left detoid with a first dose of GARDASIL (Lot# 65410/0962F). There were no illnesses at the time of the vaccination. On 21-FEB-2007 right after the vaccination the patient experienced pain in vaccinated arm, pain in chest, pain in neck, and shortness of breathe that lasted a few minutes as shot was given and removed. It was reported that there was no wheezing. Unspecified medical attention was sought. No laboratory diagnostics were performed. The patient recovered right after the shot was given (previously reported as the symptoms lasted a few days and then the patient recovered). On 30- APR-2007, the patient was vaccinated intramuscularly in the left deltoid with a second dose of GARDASIL (Lot# 657736/0389U). There were no illness at the time of the vaccination. On 30-APR-2007 right after the vaccination the patient experienced pain in vaccinated arm, pain in chest, pain in neck, and shortness of breath that lasted a few minutes as shot was given and removed. It was reported that there was no wheezing. Unspecified right after shot was given (previously reported as the symptoms lasted a few days and then the patient recovered). Additional information is not expected.
injection site was black and blue with a diameter 2.5-3 inches; little swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (injection site was black and blue with a diameter 2.5-3 inches) and VACCINATION SITE SWELLING (little swelling at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (Sulfa) and Osteoporosis since 03-Mar-2002. Concomitant products included DENOSUMAB (PROLIA) from 01-Jan-2012 to an unknown date and CALCIUM CITRATE, COLECALCIFEROL (CITRACAL + D [CALCIUM CITRATE;COLECALCIFEROL]) from 01-Jan-1999 to an unknown date for Osteoporosis.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced VACCINATION SITE DISCOLOURATION (injection site was black and blue with a diameter 2.5-3 inches) and VACCINATION SITE SWELLING (little swelling at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (injection site was black and blue with a diameter 2.5-3 inches) and VACCINATION SITE SWELLING (little swelling at the injection site) outcome was unknown.            No Treatment information was provided by the reporter.   This case was linked to MOD-2021-364370 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Significant: Patient demographic details added, medical history added, Concomitants added.
the patient was pregnant when she received a dose of VARIVAX; the patient is not experiencing any adverse effects; This prospective pregnancy report was received from a registered nurse concerning a female patient of unknown age. The patient's concurrent conditions, past medical history, concomitant medications, and drug reactions or allergies were not reported.  On an unspecified date, the patient became pregnant. Information regarding the patient's last menstrual period (LMP) and estimated date of delivery (EDD) was unknown. On 13-MAY-2019, the pregnant patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) (strength and dose not reported), one single injection, subcutaneously, lot # R021377 and expiration date 25-JUL-2020, for prophylaxis.  The patient was not experiencing any adverse effects. The outcome of the pregnancy was unknown.
Swelling in lymph node in left armpit, headache, swelling of sinuses. Swelling in neck lymph nodes
I developed what appears to be contact dermatitis around both eyes. Treated with oral steroids, prednisone eye drops, antihistamine pills and drops. Once I stop treatment it comes back
Patient was vaccinated and felt he was having some periorbital edema. MD did not appreciate that on exam, but patient was given Zyrtec 10mg PO. Vitals stable. Patient felt much less swelling after 20 minutes and felt fine to go home.
rash on his legs; This is a spontaneous report from a contactable consumer. This consumer reported that her 84-year-old husband received the first dose of BNT162B2 at single dose on 20Apr021 at 09:45AM in the right arm for COVID-19 immunisation. Relevant history included Hemophilia; Patient was born with this. He receives Factor treatment every 10 days, wound on his bottom since Feb2021, hospitalized and being treated with a wound vac, the patient was bedridden. Relevant concomitant drug included eftrenonacog alfa (ALPROLIX) for haemophilia, melatonin for Sleep apnoea syndrome, donepezil for Amnesia, ascorbic acid (VITAMIN C ACID), vitamins nos (FLINTSTONES), colestyramine (CHOLESTYRAMINE) for blood cholesterol abnormal, memantine, celecoxib for arthritis, doxazosin for blood pressure abnormal, alprazolam for relax, amlodipine for blood pressure abnormal, losartan for blood pressure abnormal, bioflavonoids nos, lecithin, quercetin, ubidecarenone (CO-Q-10 PLUS), colecalciferol (VITAMIN D3) and chondroitin sulfate, glucosamine hydrochloride (CHONDROITIN GLUCOSAMIN). The patient's wife happened to notice a rash on patient legs on 20Apr2021 about 11:30AM. Her husband was bedridden and she just took the cover off about an hour ago and that was when she spotted the rash. The physical therapist was working with her husband right now and the therapist told her the rash had not worsened and may be a little better. It looked a little lighter. Her husband was in the hospital in Feb2021, predating treatment with the vaccine, and he has a wound on his bottom from that hospitalization and was being treated with a wound vac. There is no need a visit to Emergency Room or Physician Office for the event. The outcome of event rash was resolving. Patient was planning to receive the second dose on 11May2021. No Additional Vaccines Administered on Same Date of the Pfizer Suspect. Prior Vaccination (within 4 weeks) was none. Relevant test was none.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
stiff neck; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and MUSCULOSKELETAL STIFFNESS (stiff neck) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and High cholesterol. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), GLIMEPIRIDE, METOPROLOL, METFORMIN, OMEPRAZOLE and ROSUVASTATIN for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 20-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown and MUSCULOSKELETAL STIFFNESS (stiff neck) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       HCP told patient to use hot and cold compress and Tylenol.
Information has been received from a registered nurse regarding an unknown age and gender patient. On 08-DEC-2011 at 8:00, ZOSTAVAX  (Lot # 671140/1266AA) was exposed to -13 degrees C for an estimated total time out of range of 10.5 hours. On 11-JAN-2012, the patient was administered an out of range dose of ZOSTAVAX (Lot # 671140/1266AA, expiration date 05-NOV-2012) (dose and route of administration were not provided). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
Beginning  the evening after receiving vaccine 1/5/21 patient complains of nausea, headache.  The next day the patient symptoms were chills, headache, restless legs, and a slight tremor.  By Saturday 1/9/21, the patient was experiencing worsening restless legs, and tremors to the point she could the sleep or work.  Patient reported symptoms to the pharmacy on monday 1/11/21, chills, nausea, and headache had subsided and tremors and restless legs were improving.
pt recv vax&3hrs later devel a high fever,h/a&pain from the wrist up through the shoulder in the joints which lasted for 1wk;pt was seen by a MD who dx phlebitis
Redness, Pain, Swelling, Redness traveling along arm - Urgent Care visit 9-16-2011 prescribed Prednisone.
Fever/Chills, Cough, Headache, Diahrrea, Dizziness, Nausea, Perspiration, Overall Weakness
On approx. 2/7/01, the pt developed a mild chickenpox rash. The pt sought medical attention. The nurse reported on FOLLOW-UP that the patient developed chicken pox after exposure to a classmate with the illness. Subsequently, the patient recovered. No further information is available.
little bit of chills; soreness in the muscle; The initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow-up information on 05Feb2021, this case now contains all required information to be considered valid. A contactable consumer reported that a 74-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL9269, expiration date: Not reported), via an unspecified route of administration, administered in Arm Right on 03Feb2021 14:00 as (At the age of 74-years) 1ST DOSE, SINGLE for covid-19 immunisation. The patient had no Prior Vaccinations within 4 weeks. The patient medical history was not reported. The concomitant medications included blood thinner medications. The patient family history was none. It was reported that she has had her first dose of the Pfizer COVID 19 vaccine 03Feb2021 at 14:00PM in the right arm. She felt good, came home and took a Tylenol two hours later. She had a little soreness in the muscle. She had a little bit of chills but she normally has some chills with her blood thinner medication. She is going to schedule for the second dose on 25Feb2021 but it has not opened up yet. Patient mention she keeps shrinking due to natural aging. The outcome of the event chills was not recovered and other event was recovered on 04Feb2021.  Follow-up attempts are completed. No further information is expected.
numbness/ Numbness on left side of the body; joint inflammation/Swollen joints; severe tiredness; Muscle pain; Swollen lungs; This is spontaneous report from a contactable consumer via a HCP.  A 44-years-old non pregnant female patient received first dose of BNT162B2 (solution for injection, Lot number: EL3301 expiry date: unknown) via an unspecified route of administration on 29DEC2020 01:30 PM, as a single dose for Covid-19 immunization at Nursing Home/Senior Living Facility. The patient Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19 The patient has no history of allergies to medications, food, or other products. On 19Jan2021, the patient experienced swollen lungs. On an unknown date, she experienced numbness on left side of the body, swollen joints, muscle pain and severe tiredness. She received treatment with Medecina, for the event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the event of swollen lungs was not recovered, while other events was unknown.  No follow-up attempts were needed. No further information was expected. Lot number obtained.
Tightening in my upper arm like a tournequet left on too long with tingling in my fingers.  Then swelling about 3" below the injection site, VERY hot to the touch, difficulty moving my lower arm.  The intense heat continued as the swelling moved down my arm to my elbow.  I kept moving my arm and put ice on it and that helped some.    The next day (today) it was very red and swolen and hot still, but not as hot as yesterday.
Extreme pain in right arm, could not move it for 12 hours.  36 hours later, it is better but still painful.   Nausea and low grade fever. Was told to ice it 20 minutes every hour and take ibupropen.   extreme pain!!!  Arm was immobile.
This spontaneous report was received from an 82 year old female patient, reported on herself. The patient's medical history and concurrent conditions were not reported. On 25-MAY-2016, the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml, subcutaneous (lot# and expiry date not reported). Concomitant medications included unspecified blood pressure medication. On approximately 01-JUN-2016 (reported as 1 week after vaccination), the patient developed 3 bumps on her left breast (breast mass), she then noticed one on her back and rear buttocks, and on the side of left arm. The patient sought medical attention and had received unspecified treatment. The outcome of the events was reported as not recovered. The reported did not assess the relatedness between the events and ZOSTAVAX. No product quality complain (PQC) involved. No further information provided. Additional information has been requested.
Herpes zoster keratitis; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 76 year old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   On or around 11-JUL-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced ophthalmic herpes zoster. On an unspecified date, the patient was treated by a healthcare provider for ophthalmic herpes zoster. The outcome of the event ophthalmic herpes zoster was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).   Upon internal review, the event ophthalmic herpes zoster was considered to be medically significant.
Increasing stiffness, pain --pt described as "bone on bone feeling" "like nerve damage" and pain down arm to hand--but has full use of hand.
Incident report Thursday September 14th 2017 Pharmacy front store incident from the front store. Flu shot vaccination fainted / passed out due to vaccine. Two customers came into the pharmacy for seasonal flu shots. Mother and daughter both have received prescription medication from the pharmacy in the past. Both patients had received flu vaccinations in the past without incident. Mother approached and inquired about the availability of flu shots. I greeted them and informed them we have the 17-18 flu shots available and we could take care of their vaccinations. I organized the clipboards with the paperwork for the vaccines and handed them to mother for completion. I returned to other issues in the pharmacy which required my attention while the paperwork. Once the paperwork was completed I brought them into the pharmacy for processing. There were no issues noted on the paperwork with allergic reactions or issues with previous vaccinations. After the AFLURIA had been injected daughter mentioned a hot flash and fanned herself for a moment. No other complaints or concerns when mentioned. I checked her ABCs no swelling noted or difficulty breathing reported. After administrating mother's vaccine I returned to the pharmacy to complete the paperwork to finalize the transaction. At this point I was called back to the front store daughter had felt faint and started to pass out. When I arrived in the waiting room mom was helping daughter back up to her chair. I check daughter's eyes for contact and noted they were dilated. I then assessed daughter's pulse and found it to be weak but assessed at 50. I check the ABCs and no other conditions were noted or worsening. I reassessed the pulse rate and due to the laceration on the forehead requiring attention the pulse rate could not be fully evaluated. I was able to retrieve an automatic BP cuff from the pharmacy to assist with the monitoring of daughter's vitals. First reading the BP cuff generated was 80/65 pulse 60. No worsening of condition was noted. Airway was fine, no signs of anaphylaxis noted or other distress. I continued to provide first aid to the head laceration and assess vitals and ABCs. A new BP test was run and improvement noted 82/70 and pulse 66. Due to an emerging issue with another patient I had to use the BP monitor for another patient. Pt was improving, alert to time and place and able to hold conversation and report verbally to me any distress or issue she was having while I began to assess the other patient. No other test were done. Daughter was able to leave around 5:15pm with no other issue to report.
On 4/9/2021 patient suffered from a Hemorragic Stroke on the left side of the brain making him unable to move his right leg and toes, right arm and hand, slight droop of right lip, and responding mostly in one word answers with delays at times.  He was hospitalized in the am hours, sent to ER and then to Neuro ICU for 3.5 days and then moved onto a neuro floor for 1.5 days.  On 4/13/2021 he was transported to an acute rehabilitation center to receive OT, PT and Speech Theraphy.   On 4/19/2021 patient suffered from Ischemic Stroke on the right side of the brain, he became unresponsive.  He was intubated on 4/19/2021, placed into ICU and was removed from intubation, due to poor life outcome from the 2 strokes having affected his body, on 4/21/2021.
The Patient Says he experienced feeling of her throat closing. possible trouble breathing. She felt better sitting up. and drinking fluids. She said her symptoms  subsided after 8 hours. She never sought medical attention. She said her symptoms subsided over time. She called her doctor the next day to report her experience. She said she had a flu shot before , but not recently.